Search

Search Constraints

You searched for: Author/Creator Aumais, Guy

Search Results

1. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)

2. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

3. Jejunal Wall Thickening and Ulceration in a Patient With Amyloid Light-chain (AL) Amyloidosis. Issue 3 (8th October 2020)

4. Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. Issue 11 (18th October 2019)

5. FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. (4th July 2018)

6. Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation. (2nd January 2018)

7. Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis. (2008)